Get started
L&G Pharma Breakthrough UCITS ETFL&G Pharma Breakthrough UCITS ETFL&G Pharma Breakthrough UCITS ETF

L&G Pharma Breakthrough UCITS ETF

No trades
See on Supercharts
Overview Analysis
Holdings
Discussions Technicals Seasonals

L&G Pharma Breakthrough UCITS ETF holdings


As of July 22, 2025
Symbol
Weight %
Shares
Market value
9
9969InnoCare Pharma Ltd.
5.04%
‪‪332.64 K‬‬
‪‪781.39 K‬‬USD
Z
ZVRAZevra Therapeutics, Inc.
3.85%
‪‪51.54 K‬‬
‪‪596.82 K‬‬USD
A
ALNYAlnylam Pharmaceuticals, Inc
3.58%
‪‪1.71 K‬‬
‪‪555.25 K‬‬USD
I
IONSIonis Pharmaceuticals, Inc.
3.34%
‪‪12.35 K‬‬
‪‪518.00 K‬‬USD
X
XERSXeris Biopharma Holdings, Inc.
3.25%
‪‪98.46 K‬‬
‪‪504.12 K‬‬USD
0
051910LG Chem Ltd.
3.24%
‪‪2.41 K‬‬
‪‪502.22 K‬‬USD
P
PHARMPharming Group NV
3.22%
‪‪506.67 K‬‬
‪‪499.55 K‬‬USD
O
ONCBeOne Medicines Ltd. Sponsored ADR
3.22%
‪‪1.69 K‬‬
‪‪499.55 K‬‬USD
L
LGNDLigand Pharmaceuticals Incorporated
3.11%
‪‪3.64 K‬‬
‪‪481.62 K‬‬USD
B
BCRXBioCryst Pharmaceuticals, Inc.
3.03%
‪‪54.29 K‬‬
‪‪469.58 K‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.